Cannabis is a family of plants with two primary classifications, Indica and Sativa. Despite the two falling under one cannabis family, they are widely different in their biological makeup and effects. Although marijuana can fall into either family, marijuana is linked to having psychoactive effects on the user because of its tetrahydrocannabinol or THC component-heavy makeup. On the other hand, hemp does not provide psychoactive effects because of its main component, cannabidiol or CBD and while marijuana can contain anywhere from 15% to 40% of THC concentration, hemp normally contains less than 0.3%. In fact, it is the heavy THC concentration within marijuana which caused international organizations to put restrictions on the plant, making it one of the most enforced drugs worldwide.

 Although often overshadowed by the importance of marijuana retail and branding, cannabis extraction is a vital component of any vertically integrated cannabis company. Not only do in-house extraction operations allow cannabis companies to avoid outsourcing costs, but it also enables the potential for additional revenue streams and more rapid product ideation. With cannabis edibles, extracts, and topicals expected to be legal in the Canadian market later this year, we examine some of the marijuana industry’s largest cannabis extractors.

There's a brick building on the southeast edge of Windsor run by someone who never dreamt she would help people consume cannabis.

Twenty years ago, Lisa Hogan started at Windsor Regional Hospital (WRH), where she worked her way into management at the family birthing centre.

"It was an amazing, very fulfilling career," said Hogan, marking it as a career goal.

But then Hogan's life changed. Her father was diagnosed with cancer and he made a decision that changed her life.

"My father used cannabis at the end of his life, and that's what changed my image and my view on the product," she said, sitting inside the education centre of the Natural Health Services (NHS) medical cannabis clinic that she runs.

Beloved Vancouverite Seth Rogen launched a new brand of Canadian recreational cannabis called Houseplant on Wednesday, March 27.

The Pineapple Express star founded the Toronto-based brand with screenwriter Evan Goldberg in collaboration with Canopy Growth, a global cannabis and hemp company. The company launches after years of work designing a product that will, “make it easier for people to learn to love cannabis as much as Houseplant does.”

“Houseplant is a passion we’ve brought to life through drive and dedication,” said Seth Rogen, Co-Founder of Houseplant.  “Every decision we’ve made for the business reflects the years of education, first-hand experience and respect we have for cannabis.”

Unfortunately, there is no one-size-fits-all rule when it comes to where people can smoke cannabis and where they can’t in Canada. To be on the right side of the law, it’s best to get familiar with the rules of the particular locale.

Where smoking or vaping cannabis is allowed in Canada varies depending on the province or territory, and also the city. With plenty of similarities and differences among the many jurisdictions, that means there’s no blanket answer that applies to all Canadians looking to consuming legal cannabis. So what may be fine and dandy for your friend living in, say, Hamilton, Ont., might not be the case for you in Canmore, Alta.

When it comes to growth, no industry is expected to pile on the green, at least from a revenue perspective, more than legal cannabis. This year alone, global weed sales are expected to grow from an estimated $12.2 billion to $16.9 billion (that's 38% for those of you keeping score at home), according to Arcview Market Research and BDS Analytics. Most of this growth will come from Canada's steady ramp-up of recreational pot sales, as well as California working out some early kinks in its adult-use market and supply chain.

One of the new frontiers for cannabis investing may not be the frothy windfall that some companies are expecting, a new report suggests.

The opportunity for cannabidiol – the cannabis compound du jour that’s better known as CBD – in Europe is forecast to grow at a heady clip over the next several years, but the continent is rife with a complex regulatory patchwork that could make the sector difficult to navigate, according to Bethany Gomez, managing director at Brightfield Group, which released a report Tuesday analyzing Europe's legal CBD market. 

"Europe is a very nascent cannabis market," Gomez said in a phone interview with BNN Bloomberg. "It’s just starting to take off but tailwinds are there."

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks continues with our two part series on how the growing cannabis market is boosting ancillary markets, with part two focusing specifically on acquisitions in the cannabis sector.

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the CBD and cannabis infused beverage sector and how companies are preparing to enter this new market segment.

In recent news, Food and Drug Administration Commissioner Scott Gottlieb said his agency has plans to regulate CBD edibles and will start holding public hearings on the matter as early as April.

Investors still have no idea how much recreational pot Cronos Group Inc. sold as its losses continued to mount, according to fourth-quarter earnings it reported Tuesday before the opening bell.

Cronos CRON, -1.41% CRON, -1.10%  stock tumbled 5% in Tuesday morning trading.